000			01786 a2200445 4500
005			20250518090413.0
264		0	_c20200904
008			202009s 0 0 eng d
022			_a2574-3805
024	7		_a10.1001/jamanetworkopen.2020.0274 _2doi
040			_aNLM _beng _cNLM
100	1		_aRao, Tanvi
245	0	0	_aAssociation of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries. _h[electronic resource]
260			_bJAMA network open _c03 2020
300			_ae200274 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnalgesics, Non-Narcotic _xtherapeutic use
650	0	4	_aAnalgesics, Opioid _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAnticonvulsants _xtherapeutic use
650	0	4	_aAntidepressive Agents, Tricyclic _xtherapeutic use
650	0	4	_aFormularies as Topic
650	0	4	_aHumans
650	0	4	_aInsurance Coverage _xstatistics & numerical data
650	0	4	_aMedicare Part D _xstatistics & numerical data
650	0	4	_aMuscle Relaxants, Central _xtherapeutic use
650	0	4	_aPain _xdrug therapy
650	0	4	_aPractice Patterns, Physicians' _xstatistics & numerical data
650	0	4	_aPrior Authorization
650	0	4	_aSerotonin and Noradrenaline Reuptake Inhibitors _xtherapeutic use
650	0	4	_aUnited States
700	1		_aKiptanui, Zippora
700	1		_aDowell, Paul
700	1		_aTriebwasser, Corey
700	1		_aAlexander, G Caleb
700	1		_aHarris, Ilene
773	0		_tJAMA network open _gvol. 3 _gno. 3 _gp. e200274
856	4	0	_uhttps://doi.org/10.1001/jamanetworkopen.2020.0274 _zAvailable from publisher's website
999			_c30693399 _d30693399